This metric from the AFR article is interesting.
In 2020 Etsy made $884 million of free cash and Atlassian $733m, so are valued at operating cash multiples of 40x and 100x respectively.
Now this is the definition of operating cash flow:
https://en.m.wikipedia.org/wiki/Operating_cash_flow
The International Financial Reporting Standards defines operating cash flow as cash generated from operations, less taxation and interest paid, gives rise to operating cash flows.
My risk-adjusted estimate for Bisantrene NPAT to a Big Pharma at peak sales around 2031 is USD $1.72B.
40 x USD $1.72B = USD $68.8B
40 x USD $1.72B = USD $68.8B
Contrast this with Immunomedics buyout at USD $21B which has by my calculations less than 1/3rd revenue potential of Bisantrene.
but out price, page-81
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.47 |
Change
-0.005(0.34%) |
Mkt cap ! $249.7M | |||
| Open | High | Low | Value | Volume |
| $1.48 | $1.50 | $1.46 | $129.2K | 87.73K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7418 | $1.47 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.49 | 38353 | 1 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |